Company intelligence / Profile preview

Immunetrics

Pittsburgh, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Immunetrics delivers advanced QSP modeling services and software to accelerate drug development, supporting clinical and preclinical programs through computational models that help predict biological responses and optimize trial design for a wide range of diseases

Therapeutic areas: NephrologyCardiovascularImmunologyRheumatologyMetabolic DisordersOtherOncology
Modalities: None (Immunetrics provides modeling, simulation, and quantitative systems pharmacology (QSP) services rather than developing therapeutics directly)
Industry: Drug Discovery Services

Partnerships

Clients include pharmaceutical and biotech companies for modeling servicesIntegrated with Simulations Plus/DILIsym Services

Beyond the preview

Go deeper on Immunetrics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunetrics.

Explore the full profile